Levels of Plasma Homocysteine in Obese Women Subjects Homocysteine and Obesity

被引:2
作者
YIlmaz, Vural Taner [1 ]
Coban, Erkan [2 ]
Avci, Ali Berkant [3 ]
Yilmaz, Fatih [1 ]
Cetinkaya, Ramazan [1 ]
机构
[1] Akdeniz Univ, Fac Med, Dept Internal Med, Div Nephrol, Antalya, Turkey
[2] Akdeniz Univ, Fac Med, Dept Internal Med, Antalya, Turkey
[3] Akdeniz Univ, Fac Med, Dept Internal Med, Div Rhumatol, Antalya, Turkey
来源
TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL | 2014年 / 23卷 / 02期
关键词
Obesity; Homocysteine; Body mass index; Cardiovascular risk;
D O I
10.5262/tndt.2014.1002.03
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: An increased homocysteine level is an independent risk factor for vascular diseases. The present study was designed to evaluate plasma homocysteine levels in obese women compared with non-obese healthy women. MATERIAL and METHODS: We selected 55 obese women (mean age 47.2 +/- 9.2 years) having a body mass index >= 30 kg/m(2) and 50 non-obese healthy women matched for age (mean age 46.3 +/- 9.5 years) who attended our outpatients clinic. We measured levels of homocysteine in obese and nonobese groups. RESULTS: No significant difference was observed between obese and non-obese control groups regarding the homocysteine levels (10.3 +/- 3.5 mu mol/l vs. 10.1 +/- 3.8 mu mol/l, p>0.05). In this selected study population as a whole, the correlation between homocysteine levels and body mass index did not attain statistical significance (r=0.12, p>0.05). CONCLUSION: We found that homocysteine levels were comparable between middle-aged obese and non-obese women. Our data may suggest that increased cardiovascular risk in obese women is probably not related to the homocysteine level.
引用
收藏
页码:91 / 94
页数:4
相关论文
共 26 条
  • [1] Akoglu Bora, 2006, Exp Clin Transplant, V4, P462
  • [2] Homocysteine and arteriosclerosis - Subclinical and clinical disease associations
    Bostom, AG
    Selhub, J
    [J]. CIRCULATION, 1999, 99 (18) : 2361 - 2363
  • [3] Brasileiro R. S., 2005, Nutr. Hosp., V20, P313
  • [4] American Heart Association call to action: Obesity as a major risk factor for coronary heart disease
    Eckel, RH
    Krauss, RM
    [J]. CIRCULATION, 1998, 97 (21) : 2099 - 2100
  • [5] Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
    Eikelboom, JW
    Lonn, E
    Genest, J
    Hankey, G
    Yusuf, S
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) : 363 - 375
  • [6] Insulin sensitivity and plasma homocysteine concentrations in nondiabetic obese and normal weight subjects
    Fonseca, VA
    Fink, LM
    Kern, PA
    [J]. ATHEROSCLEROSIS, 2003, 167 (01) : 105 - 109
  • [7] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [8] Plasma homocysteine as a risk factor for vascular disease - The European concerted action project
    Graham, IM
    Daly, LE
    Refsum, HM
    Robinson, K
    Brattstrom, LE
    Ueland, PM
    PalmaReis, RJ
    Boers, GHJ
    Sheahan, RG
    Israelsson, B
    Uiterwaal, CS
    Meleady, R
    McMaster, D
    Verhoef, P
    Witteman, J
    Rubba, P
    Bellet, H
    Wautrecht, JC
    deValk, HW
    Luis, ACS
    ParrotRoulaud, FM
    Tan, KS
    Higgins, I
    Garcon, D
    Medrano, MJ
    Candito, M
    Evans, AE
    Andria, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22): : 1775 - 1781
  • [9] The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
    Guh, Daphne P.
    Zhang, Wei
    Bansback, Nick
    Amarsi, Zubin
    Birmingham, C. Laird
    Anis, Aslam H.
    [J]. BMC PUBLIC HEALTH, 2009, 9
  • [10] Hyperhomocysteinemia, vascular function and atherosclerosis: Effects of vitamins
    Haynes, WG
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (05) : 391 - 399